Krishnaswamy Yeleswaram

Insider Reports History

Location: C/O Rapport Therapeutics, 1325 Boylston St., Suite 401, Boston, MA
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Krishnaswamy Yeleswaram:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Rapport Therapeutics, Inc.	Chief Development Officer	Common Stock	291K	$2.9M	$9.98	Jun 6, 2024	Direct
Rapport Therapeutics, Inc.	Chief Development Officer	Stock Option (Right to Buy)	110K			Feb 3, 2025	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Krishnaswamy Yeleswaram

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
RAPP	Rapport Therapeutics, Inc.	Feb 3, 2025	1	$0	4	Feb 4, 2025	Chief Development Officer
RAPP	Rapport Therapeutics, Inc.	Jun 6, 2024	1	$0	4	Jun 10, 2024	Chief Development Officer
RAPP	Rapport Therapeutics, Inc.	Jun 6, 2024	0	$0	3	Jun 6, 2024	Chief Development Officer